北美干眼产品市场预测至 2031 年 - 区域分析 - 按产品(人工泪液、抗炎药物、泪点塞、促泌剂、口服 Omega 补充剂等)、剂型(眼药水、凝胶、胶囊和药片等)、类型(非处方药和处方药)和分销渠道(零售药店、医院药店和网上药店)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)


No. of Pages: 104    |    Report Code: TIPRE00028871    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Dry Eye Products Market
2023 年北美干眼症产品市场价值为 38.2536 亿美元,预计到 2031 年将达到 55.8777 亿美元;预计 2023 年至 2031 年的复合年增长率为 4.9%。

干眼症患病率上升推动北美干眼症产品市场发展

干眼症 (DED) 是继屈光不正和白内障之后第三大眼科就诊原因。干眼症的患病率在发达国家尤其上升。干眼症是由多种因素引起的,会导致不适、刺激和视觉障碍。根据美国眼科学会发表的一篇文章,DED 影响全球大约十分之一的人,在不同年龄段的患病率为 5% 至 50%。根据爱尔康 2022 年发布的新闻稿,该疾病影响全球约 7.19 亿人,美国约 3800 万人。

糖尿病视网膜病变对视网膜造成的逐渐损害进一步导致干眼症。根据美国眼科学会发表的一篇文章,预计到 2030 年,全球约有 1.91 亿人患有糖尿病视网膜病变。根据美国疾病控制和预防中心 (CDC) 的数据,2021 年美国约有 960 万人(各年龄段)患有糖尿病视网膜病变。因此,糖尿病视网膜病变发病率的增加正在推动干眼症产品市场的增长。

北美干眼症产品市场概览

北美干眼症产品市场分为美国、加拿大和墨西哥。该地区的市场增长归因于人们对干眼症 (DED) 认识的提高、人口老龄化的增长、技术进步以及眼病病例的增加。此外,由于新药频繁推出导致各种药物易于获得,这是推动该地区干眼症产品市场增长的关键因素之一。

DED 是美国一种常见但未被充分诊断的疾病,人口年龄的增长可能与该疾病的患病率飙升有关。根据美国疾病控制和预防中心 (CDC) 的数据,白内障、黄斑变性、糖尿病视网膜病变和青光眼等与年龄相关的眼部疾病是美国失明和视力受损的主要原因。其他常见的眼部疾病包括弱视和斜视。到 2030 年,预计干眼症将影响多达 279 万美国男性。因此,随着干眼症发病率的上升,美国对治疗产品的需求也在上升。 2021 年 1 月,Kala Pharmaceuticals Inc. 推出了 EYSUVIS 0.25%(洛替泼诺依碳酸酯眼用混悬液),用于短期(最长两周)治疗干眼症症状。EYSUVIS 现已在美国各地的国家和地区医药配送中心上市。

北美干眼产品市场收入及预测至 2031 年(百万美元)

北美干眼产品市场细分

北美干眼产品市场分为产品、剂型、类型、分销渠道和国家/地区。

根据产品,北美干眼产品市场细分为人工泪液、抗炎药、泪点塞、促泌剂、口服欧米茄补充剂等。人工泪液部分在 2023 年占据了北美干眼产品市场的最大份额。此外,抗炎药部分细分为环孢菌素、皮质类固醇等。此外,泪点塞细分市场细分为可溶解和可拆卸。

就剂型而言,北美干眼产品市场细分为眼药水、凝胶、胶囊和片剂等。眼药水部分在 2023 年占据了北美干眼产品市场的最大份额。

按类型划分,北美干眼产品市场分为 OTC 和处方。OTC 部分在 2023 年占据了北美干眼产品市场的较大份额。

根据分销渠道,北美干眼产品市场分为零售药店、医院药店和在线药店。零售药店部分在 2023 年占据了北美干眼产品市场的最大份额。

按国家/地区划分,北美干眼产品市场细分为美国、加拿大和墨西哥。 2023 年,美国占据了北美干眼症产品市场的主导地位。

参天制药有限公司、强生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、乐敦制药有限公司、OCuSOFT Inc、博士伦医疗公司、艾伯维公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和爱尔康公司是北美干眼症产品市场的一些领先公司。

North America Dry Eye Products Strategic Insights

Strategic insights for North America Dry Eye Products involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-dry-eye-products-market-strategic-framework.webp
Get more information on this report

North America Dry Eye Products Report Scope

Report Attribute Details
Market size in 2023 US$ 3,825.36 Million
Market Size by 2031 US$ 5,587.77 Million
Global CAGR (2023 - 2031) 4.9%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 人工泪液
  • 抗炎药
  • 泪点塞
  • 促泌剂
  • 口服欧米茄补充剂
By 剂型
  • 眼药水
  • 凝胶
  • 胶囊
  • 药片
By 类型
  • OTC,处方
By 分销渠道
  • 零售药店
  • 医院药店
  • 网上药店
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Get more information on this report

    North America Dry Eye Products Regional Insights

    The regional scope of North America Dry Eye Products refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-dry-eye-products-market-geography.webp
    Get more information on this report

    The List of Companies - North America Dry Eye Products Market

    1. Santen Pharmaceutical Co Ltd
    2. Johnson & Johnson
    3. OASIS Medical
    4. URSAPHARM Arzneimittel GmbH
    5. Rohto Pharmaceutical Co Ltd
    6. OCuSOFT Inc.
    7. Bausch Health Companies Inc
    8. AbbVie Inc
    9. Prestige Consumer Healthcare Inc.
    10. Farmigea SpA
    11. Alcon AG
    Frequently Asked Questions
    How big is the North America Dry Eye Products Market?

    The North America Dry Eye Products Market is valued at US$ 3,825.36 Million in 2023, it is projected to reach US$ 5,587.77 Million by 2031.

    What is the CAGR for North America Dry Eye Products Market by (2023 - 2031)?

    As per our report North America Dry Eye Products Market, the market size is valued at US$ 3,825.36 Million in 2023, projecting it to reach US$ 5,587.77 Million by 2031. This translates to a CAGR of approximately 4.9% during the forecast period.

    What segments are covered in this report?

    The North America Dry Eye Products Market report typically cover these key segments-

  • 产品 (人工泪液, 抗炎药, 泪点塞, 促泌剂, 口服欧米茄补充剂)
  • 剂型 (眼药水, 凝胶, 胶囊, 药片)
  • 类型 (OTC,处方)
  • What is the historic period, base year, and forecast period taken for North America Dry Eye Products Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Dry Eye Products Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in North America Dry Eye Products Market?

    The North America Dry Eye Products Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Alcon AG
  • Who should buy this report?

    The North America Dry Eye Products Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Dry Eye Products Market value chain can benefit from the information contained in a comprehensive market report.